Recently, AIM announced a comprehensive deployment to integrate the DeepSeek large model, particularly in vaccine development, utilizing DeepSeek in conjunction with generative models and deep ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Deutsche Bank says Biohaven’s (BHVN) competitor Immunovant (IMVT) reported topline data for FcRn antibody batoclimab in myasthenia gravis and ...

Type I allergy, an IgE antibody triggered hypersensitivity disease, represents a common public health problem affecting about one third of the world´s population. Upon exposure to allergens, IgE ...

Immunovant said on Wednesday its drug for a type of a chronic autoimmune disease that causes muscle weakness met the main goal in a late-stage trial.

Pivotal study in MG met primary endpoint of change from baseline in MG-ADL in AChR+ population at 12 weeks, with a 5.6 point improvement in the ...

Batoclimab is an anti-FcRn treatment being developed for a range of autoimmune diseases and active thyroid eye disease (TED).

Michigan has confirmed its first measles case since last July. An Oakland County adult tested positive after recently ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells and ...